Pontin Acts as a Potential Biomarker for Poor Clinical Outcome and Promotes Tumor Invasion in Hilar Cholangiocarcinoma

<div>Immunohistochemical results of Pontin in human hilar cholangiocarcinoma tissues (400x). (a) High Pontin expression (score = 6); (b) low Pontin expression (score = 0).</div>

BioMed Research International

fig1

Figure 1

Figure 1: Pontin Acts as a Potential Biomarker for Poor Clinical Outcome and Promotes Tumor Invasion in Hilar Cholangiocarcinoma 